Updated On: 21 November, 2023 10:49 AM IST | London | IANS
Chronic liver diseases and associated cirrhosis is a common and lethal condition that account for approximately one million deaths per year globally

Image for representational purposes only. Photo Courtesy: iStock
A new type of cell therapy helped dramatically reduce serious liver-related complications that could lead to hospitalisation and death in patients with liver scarring, or cirrhosis.
The innovative new approach, by researchers at the University of Edinburgh in the UK, uses macrophage immune cells -- the cells associated with tissue repair -- derived from the patient`s own cells to treat cirrhosis.